MS
Multiple Sclerosis Progression, Disease Response Informed by Blood-Based Immune Signatures
With targeted proteomic profiling, researchers tracked down three cellular immunological subtypes showing variable disease progression features and treatment response patterns.
Metabolon Partners With Cardiff University to Identify MS Biomarkers
The company will profile plasma and cerebrospinal fluid samples from multiple sclerosis patients with the aim of identifying metabolomic markers for the disease.
Multiple Sclerosis Risk Score Provides Clues to Treating Vision Loss Condition
Researchers found that a genetic risk score improved MS prediction in individuals with optic neuritis, an eye condition that is treated differently in individuals with or without MS.
Ancient European Genome Studies Reveal Historical Population Interactions, Modern-Day Disease Clues
With an ancient European genome collection, researchers retraced population turnover events while digging into trait- and disease-related variants carried by distinct ancestral groups.
Roughly a year after its launch, the company's Multiple Sclerosis Disease Activity (MSDA) test is being used by several dozen clinics around the country.